No Data
SUS rebounded sharply and set a new high, revising upward the financial estimates for the cumulative performance in the second quarter of the fiscal year ending September 2025.
SUS (SUS) <6554.T> has surged sharply. At one point, it rose by 113 yen from the previous day to 1,031 yen, updating the year's highest price. After the market closed on the 21st, it was well received after announcing an upward revision of the financial estimates for the cumulative second quarter of the fiscal year ending September 2025 (October 2024 - March 2025). For the cumulative second quarter consolidated financial estimates, the revenue was revised from the previous 7.174 billion yen to 7.450 billion yen (an increase of 20.0% compared to the same period last year), and the operating profit was revised from 547 million yen to 810 million yen (an increase of 79% compared to the same period last year).
A soft tone and declining U.S. stocks may weigh on the market, but a solid performance at lower levels is expected.
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to have a weak development. In the U.S. stock market on the 21st, the Dow Inc fell by 971.82 points (-2.48%) to 38,170.41 dollars, marking a significant decline for four consecutive days. In addition to the statement from the National Economic Council (NEC) chairman that the Trump administration continues to consider options for the dismissal of the Federal Reserve Chairman, the president's request for preemptive interest rate cuts on Social Media has weakened trust in domestic Assets, leading to sales.
<Today's individual materials> GENOVA, SUS, ACOM, Pronexus ETC (Announced on the 21st)
▽ GENOVA <9341.T>, decided to establish a new company with 100% investment to acquire the main business of ADI.G (Kanazawa City, Ishikawa Prefecture) ▽ SUS <6554.T>, upwardly revised the consolidated financial estimates for the second quarter cumulative of the fiscal year ending September 2025 (from October 2024 to March 2025) ▽ Acom <8572.T>, downwardly revised the consolidated financial estimates for the fiscal year ending March 2025 ▽ Pronexus <7893.T>, lowered the consolidated profit estimates for the fiscal year ending March 2025 ▽ Care 21 <2373.T>, due to the sale of Stocks.
Globee, S.Y.S and others.
＜3063＞ jGroup sold its inventory assets (land and buildings in Nagoya, Aichi Prefecture) ＜3967＞ Eltes expanded its shareholder benefit program ＜4890＞ Tsubota Lab revised its forecast upwards, with the previous operating profit outlook of 0.26 billion yen changed from 0.131 billion yen ＜5575＞ Globee conducted an off-market sale of 100,000 shares ＜6554＞ SyuS revised its forecast upwards, with the first half operating profit outlook of 0.81 billion yen changed from 0.547 billion yen.
Amano, upward revision on March 25, operating profit 23 billion yen, up from 21 billion yen.
Amano <6436> announced a revision of its financial estimates for the fiscal year ending March 2025. Revenue has been revised upward from 160 billion yen to 175.4 billion yen, and operating profit has been increased from 21 billion yen to 23 billion yen. The revenue forecast is higher than the initial plan due to the demand for parking systems arising from the reopening after COVID-19, as well as the demand for new banknote issuance, which has progressed sooner than expected. Regarding profits, the increase in revenue from the parking systems, the rise in dividends from overseas group companies, and the reduction of shares held in policy stocks are also contributing factors.
SUS: Notice regarding revisions to consolidated earnings forecasts for the second quarter (interim period) of the fiscal year ending September 2025
